FREDERICK, Md., Oct. 24, 2013 /PRNewswire/ — Vaccinogen, Inc., (OTC.QB: VGEN) a cancer vaccine company, today announced that noted pediatric neurosurgeon Benjamin S. Carson, M.D. and prominent oncologist Jan B. Vermorken, M.D., Ph.D. have joined the company’s medical advisory board. Drs. Carson and Vermorken complement Vaccinogen’s existing medical advisory board members: John S. Macdonald, M.D., a highly recognized colorectal surgeon; Herbert C. Hoover, Jr., M.D., a leader in the field of oncologic surgery; and Michael G. Hanna, Jr., Ph.D., Vaccinogen’s Chairman and Chief Executive Officer and a leader in the field of cancer immunotherapy. Together, Drs. Carson and Vermorken bring broad knowledge of the global healthcare market and clinical oncology and previous clinical experience with OncoVAX®, the Company’s investigational cancer vaccine.
http://www.publicwire.com/2013/10/24/vgen-vaccinogen-names-dr-benjamin-carson-and-dr-jan-b-vermorken-to-medical-advisory-board/
No comments:
Post a Comment